Intensity modulated radiation therapy ͑IMRT͒ treatment planning typically considers beam optimization and beam delivery as separate tasks. Following optimization, a multi-leaf collimator ͑MLC͒ or other beam delivery device is used to generate fluence patterns for patient treatment delivery. Due to limitations and characteristics of the MLC, the deliverable intensity distributions often differ from those produced by the optimizer, leading to differences between the delivered and the optimized doses. Objective function parameters are then adjusted empirically, and the plan is reoptimized to achieve a desired deliverable dose distribution. The resulting plan, though usually acceptable, may not be the best achievable. A method has been developed to incorporate the MLC restrictions into the optimization process. Our in-house IMRT system has been modified to include the calculation of the deliverable intensity into the optimizer. In this process, prior to dose calculation, the MLC leaf sequencer is used to convert intensities to dynamic MLC sequences, from which the deliverable intensities are then determined. All other optimization steps remain the same. To evaluate the effectiveness of deliverable-based optimization, 17 patient cases have been studied. Compared with standard optimization plus conversion to deliverable beams, deliverable-based optimization results show improved isodose coverage and a reduced dose to critical structures. Deliverable-based optimization results are close to the original nondeliverable optimization results, suggesting that IMRT can overcome the MLC limitations by adjusting individual beamlets. The use of deliverable-based optimization may reduce the need for empirical adjustment of objective function parameters and reoptimization of a plan to achieve desired results. © 2002 American Association of Physicists in Medicine.
I. INTRODUCTION
The objective of this article is to develop a method to incorporate constraints imposed by delivery systems used for intensity modulated radiation therapy ͑IMRT͒ into the IMRT treatment plan optimization process. The proposed method unifies the IMRT optimization and IMRT multi-leaf collimator ͑MLC͒ leaf sequencing tasks, resulting in deliverable beam intensity profiles and dynamic MLC instructions at the completion of the optimization sequence.
Current IMRT beam planning systems consider the optimization and delivery of IMRT as separate tasks of a multistep process. In the optimization stage, beamlet intensity or fluence profiles are modified so as to produce the best possible dose distribution that meets the objective function specified by the treatment planner. After determination of the optimal intensity distributions, the delivery of these distributions is considered. Many methods have been proposed to convert optimized intensity profiles into those that can be achieved by the IMRT beam delivery system. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Following conversion, intensity distributions achievable with or realized by the beam delivery system ͑which are delivered to a patient, thus termed deliverable intensity distributions͒ differ from the optimized intensity distributions. In general, the more complex and the more fluctuations in the optimized intensity distribution, the greater the deviation between the optimized and deliverable intensity distributions. 4, 15 Reasons for the deviation include radiation leakage through the MLC leaves and MLC leaf tips, head scatter, and tongue-andgroove effects. Additionally, for some MLCs, issues such as the maximum leaf velocity, the minimum gap between leaf banks, and maximum interdigitation between adjacent leaves can limit the ability to reproduce an intended intensity profile. In any case, the inability to realize the intended optimum intensity distribution results in a degradation of the treatment plan quality. Because the tumor dose is renormalized to the desired prescription value following conversion, the MLC leakage and scatter typically result in the delivery of higher doses to critical structures than those optimized. To overcome this problem in clinical practice, the IMRT treatment planner empirically adjusts the IMRT objective function parameters to compensate for the observed effects and then reoptimizes the plan. This laborious trial-and-error procedure is iterated until an acceptable compromised deliverable treatment plan is achieved. Although this achievable plan still differs from the optimized one, it is deemed acceptable because it sufficiently meets the actual treatment objectives. However, this plan may be suboptimal since the objective function used during optimization differs from the criteria used to evaluate plan acceptability. Furthermore, if the optimization considered the beam delivery constraints, a better plan ͑one with a better plan quality score͒ likely would be found.
Several approaches have been taken to improve the agreement between optimized and deliverable intensity profiles by modifying the IMRT optimization process. Notably, Webb et al. 16 used periodic filtering of the intensity profiles during the optimization process to reduce intensity fluctuations, thus reducing the number of MUs required for the delivery of a schematic test case, while Alber and Nüsslin 15 included intensity smoothness as a constraint to the IMRT optimization. This is incorporated in the Hyperion IMRT program. 17 The KonRad inverse planning software ͑MRC-Systems, Heidelberg, Germany͒ also includes smoothing of the intensity pattern into the optimization process. The KonRad system gives the user the option to view the leaf sequences during the optimization, but it does not include leaf-sequencer-based deliverable fluences in the optimization process.
In other work, Webb 18 included cost functions that took into account the ''complexity'' of the intensity profiles in IMRT optimization, thus encouraging the optimizer to find less complex solutions when performing the beamlet intensity optimization. Another method was proposed by Holmes, 19 who incorporated leaf leakage and head scatter beam delivery effects into tomotherapy based IMRT optimization by including their contributions in iterative IMRT dose computation through the use of concurrent leaf sequences. To account for geometric beam delivery system limitations, Cho and Marks 20 used the projection onto convex sets method to include leaf velocity, leaf gap, and leaf synchronization constraints in the IMRT optimization loop. They applied their method to a test case and found that overor underexposures introduced by leaf trajectory limitations in one beam angle can be compensated for by the beams from other angles. Thus, by incorporating the beam delivery constraints, the resultant IMRT treatment plans better conform to the target. While their method included the beam delivery constraints, it ignored the important effect of leakage and scattered radiation from the MLC. The approach taken by Tervo and Kolmonen 21 was to incorporate the beam delivery constraints to directly optimize MLC leaf positions and delivery times for multiple static treatments ͑step-and-shoot IMRT͒. However, due to the computation complexity, they restricted their study to simple test cases with a three-leaf MLC. They found feasible solutions for the cases studied, proving that their method is viable.
In this article, we propose a simple method to incorporate beam delivery constraints into the IMRT optimization process. The method we propose can be applied to arbitrary IMRT systems ͑dynamic and step-and-shoot͒, because the beam delivery constraints are accounted for in the fluenceto-trajectory or MLC leaf sequencing conversion program. In view of the fact that our IMRT system utilizes the sweeping window dynamic MLC method of delivering the IMRT field, this article uses that method in its test cases.
II. METHODS AND MATERIALS

A. IMRT optimization system
The IMRT optimization system used in this study was the Medical College of Virginia ͑MCV͒ IMRT system developed in-house. 22 This system is coupled to the ADAC Pinnacle 3 treatment-planning system ͑ADAC Laboratories, Milpitas, CA͒, which is used for patient contouring, beam energy and angle selection, isodose displays, dose-volume analysis, and other treatment-planning tasks. The MCV IMRT system employs a gradient-based search algorithm to adjust the intensity of each beam ray in the intensity matrix based on the dose or dose-volume constraints on points along the ray. During the intensity update, changes in dose along a given beam ray are presumed to be directly proportional to the change of the intensity of the beam ray passing through a point. Lateral spread of radiation is neglected in the intensity update; however, it is accounted for at the completion of each iteration by recalculating the dose. Traditional use of the IMRT optimization process is described in detail in Wu and Mohan 22 and is summarized here for completeness ͑Fig. 1͒. Optimization starts with an initial set of beamlet ray intensities ͑box 1͒. Intensities in this step can be either uniform, random, or a result of some previous beam optimization. The dose distributions for each beam using these intensity distributions are then computed ͑box 2͒ utilizing Pinnacle's superposition-convolution dosecalculation algorithm. The value of the plan objective function is then evaluated to obtain the plan quality score ͑box 3͒, which is then evaluated for convergence or termination ͑box 4͒. Provided that the optimization is instructed to continue, beamlet intensity updates are obtained using Newton's method ͑box 5͒. The intensity update only crudely includes beam delivery limitations, for example, by limiting the maximum gradient between adjacent beamlets along a single leaf of the MLC or by imposing a minimum intensity value to account for radiation transmitted through and scattered from the MLC. Following the intensity update, the dose and plan objective functions are reevaluated ͑boxes 2 and 3͒. The optimization process terminates when the difference between the current and previous plan quality scores falls below some predefined threshold ͑typically 0.5 or 1.0% of the current score͒, when the plan quality score rises, or when a predetermined number of iterations has been performed. At the completion of the optimization, the beamlet ray intensities and dose distributions represent those from what is termed the optimized treatment plan.
Clinical acceptability of an IMRT treatment plan, however, is not based upon the optimized plan. Rather, it is based upon the deliverable treatment plan. The deliverable treatment plan is obtained by processing the optimized plan through a leaf sequence generator in which the dynamic MLC leaf sequences required to best approximate the optimized intensity distribution are determined. The leaf sequence generator process we use has been described by Mohan et al. 4, 5 and includes a Savitzky-Golay filter to smooth the intensity profiles. 23 From the leaf sequences, the deliverable intensity distribution is determined and the deliverable dose distribution is computed. The deliverable dose distribution is used to judge the acceptability of a treatment plan. Since the deliverable and optimized treatment plans differ, the plan quality is compromised. Typically, the dose to critical structures is increased. For instances in which a deliverable plan is judged to be unacceptable, the plan objective function is modified manually by the treatment planner, and the optimization process is reinitiated. This often results in overspecification of the plan constraints. For example, to achieve an actual dose-volume constraint for the spinal cord of a maximum of 45 Gy to 1% of the volume, the specified dose-volume constraint might need to be a maximum of 38 Gy to 1% of the volume to achieve an acceptable plan. Similarly, the objectives and constraints for other structures might need to be modified. This iterative adjustment of plan objective values is one of the most time-consuming aspects of IMRT planning since the objective modifications required are patient case specific. At the completion of these processes, an acceptable plan is obtained. Although acceptable, this plan is not necessarily optimum because the final dose distribution differs from that used during the optimization. 
B. Deliverable-based optimization method
The general flow diagram for the optimization that incorporates delivery constraints is shown in Fig. 2 . This process is similar to the traditional IMRT optimization flow except that the computation of leaf sequences and deliverable intensities has been moved inside of the optimization loop immediately prior to the dose computation ͑from boxes 7 and 8 in Fig. 1 to boxes 1a and 1b in Fig. 2͒ . The deliverable intensities ͑box 1b, Fig. 2͒ are derived from the MLC trajectories ͑box 1a, Fig. 2͒ . They include all restrictions of the MLC delivery and incorporate the best available approximations related to the transmission and scattering characteristics of the MLC. These deliverable intensities are used to compute the deliverable dose distributions ͑D D , box 2, Fig. 2͒ , which are used in turn to evaluate the plan objective function ͑box 3, Fig. 2͒ , hence, the plan quality score. At the completion of deliverable-based optimization, the optimized solution is, in fact, deliverable to a patient, and dynamic MLC leaf sequences exist. Thus, no further processing or conversions are required. Furthermore, the result is optimal for the constraints and objectives specified.
C. Patients and plans
The deliverable-based optimization method was evaluated by developing alternative treatment plans for 17 IMRT patients ͑see Table I͒. Eleven of the case studies were head and neck cancer cases, with the remainder being prostate ͑3͒, spine, cervix, and lung. The large number of head and neck cases chosen reflect the fact that typically, they provide the greatest challenge to IMRT optimization systems. The IMRT patient plans for each patient were initially developed using the current traditional practice for IMRT. That is, patient plans were optimized, and then, following optimization, they were converted into deliverable intensity and dose distributions. Deliverable dose distributions were normalized to produce the desired target coverage for the treatment site ͑e.g., 98% of PTV to 70 Gy͒. Based on the deliverable dose distribution, the treatment planner then adjusted the objective function parameters ͑dose-volume constraints and penalties͒ and repeated the optimization and conversion to a deliverable plan until an acceptable plan was obtained. It should be restated that this time-consuming iterative process required overspecification of critical structure constraints during the optimization process so that following conversion to deliverable distributions, the desired dose-volume constraints were obtained.
Deliverable-based optimization was evaluated using two different optimization starting points. In one, initial intensities were obtained from the results of the traditional optimization plus conversion to deliverable intensities. In the other, FIG. 3 . Isodose profiles through a transverse slice for patient 1. ͑a͒ The nondeliverable TR opt plan, ͑b͒ the TR opt ϩDEL plan, ͑c͒ the deliverable-based optimized TR opt ϩDEL opt plan, and ͑d͒ the deliverable-based optimized DEL opt plan. a uniform initial intensity distribution was used, thus, deliverable-based optimization was performed for all iterations. In both cases, the optimization was performed using the same constraints as those specified for the original optimization.
To evaluate the effectiveness of deliverable-based optimization, results were compared with the original ͑nondeliver-able͒ optimized plans and with the original deliverable plans. Plan quality scores produced by the optimizer were compared, because it is this value that is being minimized by the IMRT optimization system. Plan quality scores were normalized to the plan quality score for original ͑non-deliverablebased͒ optimization. Furthermore, isodose distributions and dose-volume histograms ͑DVHs͒ were compared. Additional dose-volume data were tabulated to evaluate the potential benefit of applying the deliverable-based optimization. The number of monitor units required to deliver the patient treatment plan were also tabulated for comparison. ͑Note that for the same quality of competing treatment plans, the one that delivers the treatment in fewer MUs is preferred.͒ Figure 3 shows a transverse slice for patient 1 using traditional optimization ͑labeled TR opt ͒, traditional optimization followed by conversion to deliverable intensity and dose distributions ͑labeled TR opt ϩDEL͒, traditional optimization followed by deliverable-based optimization ͑labeled TR opt ϩDEL opt ͒, and deliverable-based optimization for all iterations ͑labeled DEL opt ͒. The PTV dose-volume coverage is very similar for the plans because this was the primary IMRT goal. The differences between the plans are most apparent for the critical structures. While for the TR opt case, the spinal cord is spared by the 40 Gy isodose line, when beam delivery is considered (TR opt ϩDEL), the spinal cord is transected by this isodose line. By basing optimization upon the deliverable intensity distributions, either TR opt ϩDEL opt or DEL opt , the sparing of the spinal cord is restored. Dosevolume histograms for this patient are displayed in Fig. 4 . The structure dose-volume constraints used during the optimization are indicated with a small arrow on the figure. The TR opt ϩDEL plan has a shift of the DVHs for the critical structures to higher dose values, while using deliverablebased optimization results in DVHs closer to the TR opt plan. The dose-volume constraint for the cord plus brainstem is met for the TR opt , TR opt ϩDEL opt and DEL opt plans, but not for the TR opt ϩDEL plan. For the right parotid, none of the optimizations achieves the dose-volume constraint. However, the deliverable-based optimizations result in a lower dose to the right parotid when compared with the TR opt ϩDEL plan. Note, the dose-volume constraints correspond to those used to make the initial TR opt ϩDEL plan acceptable. Thus, a solution was obtained readily for this overconstrained plan. Alternatively, if the dose-volume constraints for this plan had been set to the desired values initially, deliverable-based optimization would have reproduced these delivery constraints without having to iteratively modify the dose-volume constraints to meet the desired objective function. Figure 5 shows the total plan quality score values versus the iteration number for patient 1 for the different types of optimization. To ease the comparison between the various plans, the plan quality score has been normalized to that for the TR opt plan. The total score is calculated based on all constraints for the treatment plan. A lower total score indicates that the plan objective function is better met, hence is termed a better plan. Following traditional optimization, when beam delivery is taken into account, the plan quality score rises to 2.5. This corresponds to the plan quality score for the TR opt ϩDEL plan. When optimization considers the beam delivery, the final optimized plan scores are 1.40 for both the TR opt ϩDEL opt and the DEL opt cases.
III. RESULTS AND DISCUSSION
The other patient cases studied showed similar results in terms of the isodose profiles, DVHs, and plan quality scores. A summary of the plan score values obtained for each optimization type for all patients is given in Table I . Also given in the table is the plan quality score, which corresponds to the initiation of the optimization with uniform intensity distributions. For ease in comparison, the plan quality scores for a given patient were normalized to the TR opt plan value for that patient. For all patients, TR opt ϩDEL opt plans had a better plan quality score compared with the TR opt ϩDEL plans. For three patients the DEL opt quality score was higher than the TR opt ϩDEL score ͑patients 3, 9 and 12͒. Similarly, for a few patients, the final plan quality scores for the TR opt ϩDEL opt and the DEL opt plans differed. The reason for this is not entirely clear. The MLC leaf sequencer can dampen the optimization loop intensity adjustment, causing the change in score between iterations to be reduced. In these cases, convergence, defined to be the relative difference between sequential plan quality scores, may be indicated earlier. It also is possible that inclusion of the MLC leaf sequencer in the optimization loop is causing multiple minima to exist in the solution space by forbidding feasible solutions from being tested. That is, since the intensity update ͑box 5, Fig. 2͒ does not consider whether the intensity change is possible, the deliverability step ͑box 1b, of Fig. 2͒ might negate the intensity update when the intensity update is not possible. This can occur repeatedly. One method to avoid potential local minima would be to use a stochastic optimization algorithm instead of the gradient-based algorithm used in this study. Alternatively, if the intensity update directly considered the plausibility of the delivery, the optimizer instead would have changed beamlets from other beams to achieve a similar, but possible, result.
To further compare the optimization methods, the doses at the dose-volume objective values were compared. These are summarized for the cord or cord plus brainstem objective for the 11 head and neck cases in Table II. The table gives the dose-volume objective and, for each plan, the difference between the planned dose and the desired dose at the objective function specified volume. The cord dose for the TR opt ϩDEL plan in all cases is greater than that for the deliverable-based optimized plans. In most cases, the deliverable-based optimization was not able to reproduce the TR opt dose levels, however, improvements over TR opt ϩDEL were always observed. Similar results are observed for other objective function parameters. In all cases, deliverable-based optimization achieves the objective function dose better than the TR opt ϩDEL method. This is most clearly reflected in the plan quality scores summarized in Table 1 .
The number of monitor units ͑MUs͒ required to deliver the deliverable treatment plans for each patient are summarized in Table III . In all cases, the deliverable-based optimization cases required a fewer number of MUs to deliver the patient plan. On average, 68% fewer MUs were required for TR opt ϩDEL opt plans, while 57% fewer MUs were required for DEL opt plans. The reduction in MUs is apparently due to the intensity filtering and smoothing present in the leafsequencing algorithm that is repeatedly applied during deliverable-based optimization. Since the DEL opt plan requires more deliverable-based optimization iterations for convergence, the filtering process is applied more often; hence, fewer MUs are required. In both cases, the resultant plans from deliverable-based optimization result in improved treatment plan quality in terms of dose distribution and treatment delivery efficiency.
IV. CONCLUSIONS
The current practice in IMRT optimization of considering beam optimization and beam delivery as separate indepen-TABLE II. The cord or cord/brainstem dose-volume objective function criteria for the 11 head and neck cases. Also, the difference between the plan dose and the objective function dose at the volume corresponding to the dose-volume constraint is given for each planning method. For example, for patient 1, the first cordϩbrainstem dose-volume constraint was that no more than 10% of the volume receive more than 37 Gy. For the TR opt plan, no more than 10% of the volume received a dose in excess of 37.00-1.50ϭ35. dent tasks results in the delivery of suboptimal treatment plans to patients. The conversion of an optimized dose distribution to one that can be delivered to a patient with an MLC following optimization leads to significant differences between the delivered and the optimized dose distributions. This degrades the plan quality, typically resulting in higher doses to critical structures due to radiation transmitted and scattered from the MLC. By incorporating the beam delivery constraints directly into the optimization process by invoking the MLC leaf sequencing algorithm and subsequent conversion to deliverable intensities, these differences are minimized and the resultant plans better meet the plan objective function. This suggests that IMRT optimization can account for and partially overcome the MLC limitations by adjusting individual beamlets to achieve a better optimized plan. There are several advantages to deliverable-based optimization. The results of the optimization process are directly deliverable. At the completion of the optimization, no additional conversion between optimized and deliverable intensity or dose distributions is required. Because the beams resulting from deliverable-based optimization best meet the specified treatment objectives, the trial and error procedure of adjusting ͑overspecifying͒ the objective function and reoptimizing the plan should be greatly reduced. Furthermore, because the leaf sequencer smoothes the beam intensity distributions, the deliverable-based optimization method results in more efficient beam delivery requiring fewer monitor units.
The deliverable-based optimization method proposed here lends itself to arbitrary dose calculation algorithms. The radiation leakage from the MLC is incorporated into the IMRT optimization process and dose calculation algorithm through the intensity matrix output by the trajectory-to-fluence calculation following the MLC leaf sequencer.
The deliverable-based optimization method is applicable to arbitrary IMRT beam delivery methods. For either dynamic sliding window IMRT or step-and-shoot IMRT, one must merely reorder the processes performed by inserting the leaf sequencing routines into the optimization loop. However, the effect of intensity filtration in the MLC leaf sequencing loop may dampen the plan score gradient, causing early convergence, and hence should be used with caution. This may result in poorer plans, as indicated by the plan quality score, when deliverable-based optimization is used for all iterations (DEL opt ) and may be due to use of a gradient-based optimization algorithm. Note that when deliverable-based optimization is used only after initial convergence, the TR opt ϩDEL opt plan quality score is limited by the TR opt ϩDEL score. Hence, compared with the TR opt ϩDEL plan, a better plan, as indicated by the plan quality score, is ensured by use of the TR opt ϩDEL opt method.
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a͒ TABLE III. The number of monitor units required to deliver each of the deliverable treatment plans. The numbers in parenthesis are the MUs normalized to those for the TR opt ϩDEL plan.
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